The post Live Nation CEO says demand is unmistakable, concert tickets are underpriced appeared on BitcoinEthereumNews.com. Live Nation CEO Michael Rapino and Smith Entertainment Group CEO Ryan Smith said this week live events are more central than ever to culture and commerce in a post-pandemic world. The executives spoke at CNBC Sport and Boardroom’s Game Plan conference on Tuesday, saying the demand for in-person events has been unmistakable. “No matter what you bring to that table that day, you unite around that one shared experience,” Rapino said. “For those two hours, I tend to drop whatever baggage I have and have a shared moment.” According to Goldman Sachs, the live music industry is expected to grow at a 7.2% compounded annual rate through 2030, fueled by millennials and Gen Z. Smith bought the Utah Jazz in 2020 and launched a new NHL franchise in the state in 2024. “In sports, we’re really media companies,” Smith said. “We’ve got talent, we’ve got distribution. We’re putting on a show or a wedding or something every night.” Get the CNBC Sport newsletter directly to your inbox The CNBC Sport newsletter with Alex Sherman brings you the biggest news and exclusive interviews from the worlds of sports business and media, delivered weekly to your inbox. Subscribe here to get access today. Rapino also emphasized how the economics of music have shifted. With streaming revenue dwarfed by touring income, live shows have become one of artists’ primary sources of revenue. “The artist is going to make 98% of their money from the show,” he said. “We just did Beyonce’s tour. She’s got 62 transport trucks outside. That’s a Super Bowl she’s putting on every night.” Despite headlines about rising ticket prices, Rapino argued that concerts are still underpriced compared to sporting events. “In sports, I joke it’s like a badge of honor to spend 70 grand for Knicks courtside,” Rapino said.… The post Live Nation CEO says demand is unmistakable, concert tickets are underpriced appeared on BitcoinEthereumNews.com. Live Nation CEO Michael Rapino and Smith Entertainment Group CEO Ryan Smith said this week live events are more central than ever to culture and commerce in a post-pandemic world. The executives spoke at CNBC Sport and Boardroom’s Game Plan conference on Tuesday, saying the demand for in-person events has been unmistakable. “No matter what you bring to that table that day, you unite around that one shared experience,” Rapino said. “For those two hours, I tend to drop whatever baggage I have and have a shared moment.” According to Goldman Sachs, the live music industry is expected to grow at a 7.2% compounded annual rate through 2030, fueled by millennials and Gen Z. Smith bought the Utah Jazz in 2020 and launched a new NHL franchise in the state in 2024. “In sports, we’re really media companies,” Smith said. “We’ve got talent, we’ve got distribution. We’re putting on a show or a wedding or something every night.” Get the CNBC Sport newsletter directly to your inbox The CNBC Sport newsletter with Alex Sherman brings you the biggest news and exclusive interviews from the worlds of sports business and media, delivered weekly to your inbox. Subscribe here to get access today. Rapino also emphasized how the economics of music have shifted. With streaming revenue dwarfed by touring income, live shows have become one of artists’ primary sources of revenue. “The artist is going to make 98% of their money from the show,” he said. “We just did Beyonce’s tour. She’s got 62 transport trucks outside. That’s a Super Bowl she’s putting on every night.” Despite headlines about rising ticket prices, Rapino argued that concerts are still underpriced compared to sporting events. “In sports, I joke it’s like a badge of honor to spend 70 grand for Knicks courtside,” Rapino said.…

Live Nation CEO says demand is unmistakable, concert tickets are underpriced

Live Nation CEO Michael Rapino and Smith Entertainment Group CEO Ryan Smith said this week live events are more central than ever to culture and commerce in a post-pandemic world.

The executives spoke at CNBC Sport and Boardroom’s Game Plan conference on Tuesday, saying the demand for in-person events has been unmistakable.

“No matter what you bring to that table that day, you unite around that one shared experience,” Rapino said. “For those two hours, I tend to drop whatever baggage I have and have a shared moment.”

According to Goldman Sachs, the live music industry is expected to grow at a 7.2% compounded annual rate through 2030, fueled by millennials and Gen Z.

Smith bought the Utah Jazz in 2020 and launched a new NHL franchise in the state in 2024.

“In sports, we’re really media companies,” Smith said. “We’ve got talent, we’ve got distribution. We’re putting on a show or a wedding or something every night.”

Get the CNBC Sport newsletter directly to your inbox

The CNBC Sport newsletter with Alex Sherman brings you the biggest news and exclusive interviews from the worlds of sports business and media, delivered weekly to your inbox.

Subscribe here to get access today.

Rapino also emphasized how the economics of music have shifted. With streaming revenue dwarfed by touring income, live shows have become one of artists’ primary sources of revenue.

“The artist is going to make 98% of their money from the show,” he said. “We just did Beyonce’s tour. She’s got 62 transport trucks outside. That’s a Super Bowl she’s putting on every night.”

Despite headlines about rising ticket prices, Rapino argued that concerts are still underpriced compared to sporting events.

“In sports, I joke it’s like a badge of honor to spend 70 grand for Knicks courtside,” Rapino said. “When you read about the ticket prices going up, it’s still an average concert price [of] $72. Try going to a Laker game for that, and there’s 80 of them [in a season].”

The cost of admission to movies, theaters and concerts rose 3.4% in August from a year earlier, according to the Bureau of Labor Statistics’ consumer price index data, outpacing the full index’s increase of 2.9%. Meanwhile the cost of admission to sporting events fell 0.5% compared to the same time last year.

Ryan Smith attends a media opportunity prior to the premier game for the Utah Hockey Club at Delta Center in Salt Lake City on Oct. 8, 2024.

Bruce Bennett | Getty Images Sport | Getty Images

Looking ahead, both executives are betting heavily on Salt Lake City as a growth market. Smith and Rapino are partnering on a new downtown entertainment district anchored by sports and music venues.

The plan is to eventually host 100 to 200 nights of events a year, from NBA and NHL games to major concerts.

“If we do our job, that’s probably a million people coming downtown,” Smith said. “The impact it has on a city and businesses is almost indescribable.”

Rapino also said technology, including AI-driven ticketing, could make buying tickets smoother.

“Most websites are going to be challenged in the future, as you’re going to use that chatbot,” Rapino said. “We think ticketing, and how you find that ticket and how you can get that ticket, needs to be improved.”

Source: https://www.cnbc.com/2025/09/17/live-nation-ceo-demand-concert-tickets-underpriced.html

Market Opportunity
ALEX Lab Logo
ALEX Lab Price(ALEX)
$0.00089
$0.00089$0.00089
-2.19%
USD
ALEX Lab (ALEX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26